| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Abdominal | 46 | 2021 | 1186 | 7.100 |
Why?
|
| Elastin | 25 | 2014 | 308 | 6.230 |
Why?
|
| Biocompatible Materials | 35 | 2019 | 1736 | 4.360 |
Why?
|
| Blood Vessel Prosthesis | 33 | 2021 | 934 | 3.960 |
Why?
|
| Blood Vessel Prosthesis Implantation | 36 | 2021 | 1391 | 3.720 |
Why?
|
| Thrombomodulin | 12 | 2014 | 102 | 3.060 |
Why?
|
| Aortic Rupture | 11 | 2021 | 312 | 2.430 |
Why?
|
| Biomimetic Materials | 10 | 2015 | 179 | 2.350 |
Why?
|
| Tissue Engineering | 20 | 2020 | 1880 | 2.340 |
Why?
|
| Polymers | 19 | 2019 | 1621 | 2.250 |
Why?
|
| Thrombin | 11 | 2015 | 598 | 2.190 |
Why?
|
| Cross-Linking Reagents | 11 | 2013 | 694 | 1.920 |
Why?
|
| Vascular Surgical Procedures | 27 | 2021 | 1476 | 1.890 |
Why?
|
| Aortography | 9 | 2021 | 437 | 1.890 |
Why?
|
| Endovascular Procedures | 14 | 2021 | 1980 | 1.850 |
Why?
|
| Collagen | 12 | 2020 | 2688 | 1.810 |
Why?
|
| Heparin | 9 | 2023 | 1637 | 1.790 |
Why?
|
| Polyethylene Glycols | 20 | 2021 | 1182 | 1.740 |
Why?
|
| Thrombosis | 14 | 2021 | 2968 | 1.600 |
Why?
|
| P-Selectin | 3 | 2021 | 601 | 1.570 |
Why?
|
| Threonine | 3 | 2018 | 279 | 1.520 |
Why?
|
| Syndecan-1 | 5 | 2014 | 165 | 1.510 |
Why?
|
| Membrane Glycoproteins | 10 | 2023 | 3771 | 1.490 |
Why?
|
| Polytetrafluoroethylene | 9 | 2021 | 233 | 1.480 |
Why?
|
| Micelles | 5 | 2014 | 203 | 1.370 |
Why?
|
| Stents | 32 | 2021 | 3282 | 1.360 |
Why?
|
| Tissue Scaffolds | 6 | 2017 | 956 | 1.310 |
Why?
|
| Thromboplastin | 5 | 2015 | 291 | 1.310 |
Why?
|
| Peptides | 14 | 2014 | 4410 | 1.290 |
Why?
|
| Islets of Langerhans Transplantation | 6 | 2011 | 745 | 1.260 |
Why?
|
| Oligosaccharides | 5 | 2018 | 414 | 1.210 |
Why?
|
| Islets of Langerhans | 7 | 2012 | 1352 | 1.190 |
Why?
|
| Cysteine Endopeptidases | 5 | 2016 | 563 | 1.180 |
Why?
|
| Angioplasty | 10 | 2013 | 364 | 1.160 |
Why?
|
| Aortic Aneurysm, Thoracic | 12 | 2013 | 691 | 1.150 |
Why?
|
| Endoleak | 4 | 2021 | 106 | 1.110 |
Why?
|
| Coated Materials, Biocompatible | 5 | 2021 | 319 | 1.110 |
Why?
|
| Surface Properties | 17 | 2019 | 1184 | 1.100 |
Why?
|
| Polysaccharides | 5 | 2020 | 1059 | 1.090 |
Why?
|
| Muscle, Smooth, Vascular | 11 | 2015 | 1504 | 1.090 |
Why?
|
| Cell Adhesion | 13 | 2017 | 3144 | 1.080 |
Why?
|
| Phospholipids | 9 | 2006 | 784 | 1.030 |
Why?
|
| Recombinant Proteins | 16 | 2020 | 6621 | 1.020 |
Why?
|
| Glycopeptides | 2 | 2017 | 226 | 1.010 |
Why?
|
| Hemostasis | 3 | 2021 | 458 | 1.000 |
Why?
|
| Materials Testing | 14 | 2019 | 867 | 0.980 |
Why?
|
| Biopolymers | 3 | 2014 | 189 | 0.970 |
Why?
|
| Membranes, Artificial | 5 | 2012 | 378 | 0.960 |
Why?
|
| Specialties, Surgical | 3 | 2019 | 391 | 0.960 |
Why?
|
| Immunomodulation | 2 | 2020 | 541 | 0.950 |
Why?
|
| Aneurysm, Ruptured | 3 | 2017 | 452 | 0.950 |
Why?
|
| Nucleic Acids | 2 | 2024 | 182 | 0.930 |
Why?
|
| Collagen Type I | 4 | 2013 | 592 | 0.910 |
Why?
|
| Lactose | 5 | 2006 | 95 | 0.910 |
Why?
|
| Drug Design | 3 | 2020 | 1076 | 0.910 |
Why?
|
| Aminoacyltransferases | 4 | 2016 | 51 | 0.890 |
Why?
|
| Nanotechnology | 5 | 2012 | 710 | 0.890 |
Why?
|
| Guided Tissue Regeneration | 2 | 2015 | 85 | 0.890 |
Why?
|
| Prosthesis Failure | 9 | 2021 | 1206 | 0.890 |
Why?
|
| Alginates | 4 | 2017 | 252 | 0.880 |
Why?
|
| Glycomics | 2 | 2020 | 123 | 0.840 |
Why?
|
| Aorta, Abdominal | 9 | 2021 | 646 | 0.800 |
Why?
|
| Protein Engineering | 4 | 2011 | 538 | 0.800 |
Why?
|
| Fibronectins | 7 | 2013 | 726 | 0.800 |
Why?
|
| Glucuronidase | 1 | 2023 | 207 | 0.790 |
Why?
|
| Vascular Grafting | 3 | 2018 | 143 | 0.790 |
Why?
|
| Heart Function Tests | 6 | 2012 | 328 | 0.760 |
Why?
|
| Staphylococcus aureus | 4 | 2016 | 1453 | 0.750 |
Why?
|
| Biomimetics | 3 | 2006 | 172 | 0.730 |
Why?
|
| Proteoglycans | 6 | 2004 | 837 | 0.730 |
Why?
|
| Societies, Medical | 7 | 2021 | 3743 | 0.720 |
Why?
|
| Animals | 83 | 2023 | 168768 | 0.720 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2021 | 233 | 0.720 |
Why?
|
| Chemotaxis | 4 | 2014 | 607 | 0.720 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2015 | 687 | 0.720 |
Why?
|
| Aorta | 11 | 2013 | 2062 | 0.710 |
Why?
|
| Practice Guidelines as Topic | 7 | 2021 | 7282 | 0.650 |
Why?
|
| Extracellular Matrix | 7 | 2020 | 1741 | 0.650 |
Why?
|
| Macrophages | 5 | 2020 | 5660 | 0.640 |
Why?
|
| Syndecan-4 | 7 | 2007 | 44 | 0.640 |
Why?
|
| Nanoparticles | 3 | 2024 | 1905 | 0.620 |
Why?
|
| Heparitin Sulfate | 4 | 2023 | 225 | 0.620 |
Why?
|
| Arterial Occlusive Diseases | 6 | 2012 | 793 | 0.620 |
Why?
|
| Blood Platelets | 9 | 2019 | 2509 | 0.620 |
Why?
|
| Problem-Based Learning | 1 | 2021 | 361 | 0.610 |
Why?
|
| Biotin | 4 | 2013 | 254 | 0.610 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2020 | 209 | 0.610 |
Why?
|
| Tensile Strength | 9 | 2020 | 335 | 0.610 |
Why?
|
| Perioperative Care | 12 | 2018 | 1002 | 0.590 |
Why?
|
| Mechanical Phenomena | 3 | 2013 | 140 | 0.590 |
Why?
|
| Oligopeptides | 5 | 2017 | 1189 | 0.590 |
Why?
|
| Renal Artery Obstruction | 6 | 2013 | 248 | 0.580 |
Why?
|
| Single-Chain Antibodies | 5 | 2020 | 108 | 0.580 |
Why?
|
| Aortic Diseases | 8 | 2011 | 743 | 0.580 |
Why?
|
| Ischemia | 10 | 2017 | 1907 | 0.560 |
Why?
|
| Nanofibers | 2 | 2014 | 66 | 0.560 |
Why?
|
| Photochemistry | 4 | 2006 | 238 | 0.560 |
Why?
|
| Molecular Structure | 11 | 2011 | 1899 | 0.560 |
Why?
|
| Fibrinolytic Agents | 5 | 2020 | 2158 | 0.550 |
Why?
|
| Angioplasty, Balloon | 9 | 2013 | 653 | 0.550 |
Why?
|
| Molecular Mimicry | 3 | 2006 | 201 | 0.540 |
Why?
|
| Proteins | 5 | 2024 | 6100 | 0.540 |
Why?
|
| Venous Valves | 1 | 2015 | 13 | 0.540 |
Why?
|
| Renal Artery | 6 | 2001 | 399 | 0.540 |
Why?
|
| Stress, Mechanical | 11 | 2014 | 1686 | 0.520 |
Why?
|
| Education, Medical, Graduate | 5 | 2021 | 2291 | 0.520 |
Why?
|
| Nanostructures | 2 | 2012 | 551 | 0.520 |
Why?
|
| Humans | 195 | 2023 | 744366 | 0.520 |
Why?
|
| Hernia | 1 | 2015 | 71 | 0.520 |
Why?
|
| Endarterectomy, Carotid | 10 | 2013 | 546 | 0.520 |
Why?
|
| Postoperative Complications | 30 | 2021 | 15297 | 0.510 |
Why?
|
| Bacterial Adhesion | 1 | 2016 | 316 | 0.510 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2021 | 1443 | 0.500 |
Why?
|
| Arteriosclerosis | 6 | 2002 | 1092 | 0.500 |
Why?
|
| Hydrogels | 5 | 2012 | 724 | 0.500 |
Why?
|
| Fascia | 1 | 2015 | 135 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 17 | 2021 | 21833 | 0.500 |
Why?
|
| General Surgery | 5 | 2019 | 1636 | 0.500 |
Why?
|
| Health Care Sector | 1 | 2016 | 194 | 0.490 |
Why?
|
| Prosthesis Design | 9 | 2011 | 2110 | 0.490 |
Why?
|
| Cell Membrane | 6 | 2011 | 3749 | 0.490 |
Why?
|
| Microscopy, Electron, Scanning | 10 | 2011 | 963 | 0.480 |
Why?
|
| Azides | 3 | 2013 | 116 | 0.480 |
Why?
|
| Aorta, Thoracic | 5 | 2011 | 1084 | 0.480 |
Why?
|
| Rats | 20 | 2021 | 24252 | 0.480 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 5 | 2014 | 641 | 0.480 |
Why?
|
| Sulfhydryl Compounds | 2 | 2011 | 298 | 0.480 |
Why?
|
| Interprofessional Relations | 2 | 2019 | 1011 | 0.470 |
Why?
|
| Drug Delivery Systems | 6 | 2024 | 2219 | 0.470 |
Why?
|
| Macrophages, Peritoneal | 1 | 2014 | 251 | 0.470 |
Why?
|
| Aortic Aneurysm | 5 | 2002 | 644 | 0.460 |
Why?
|
| Platelet Aggregation Inhibitors | 9 | 2020 | 3070 | 0.460 |
Why?
|
| Microvessels | 2 | 2015 | 544 | 0.450 |
Why?
|
| Peritonitis | 2 | 2016 | 365 | 0.450 |
Why?
|
| Rheology | 6 | 2012 | 345 | 0.450 |
Why?
|
| Protein C | 3 | 2011 | 138 | 0.450 |
Why?
|
| Platelet Activation | 6 | 2020 | 674 | 0.440 |
Why?
|
| Macrophage Activation | 1 | 2016 | 560 | 0.440 |
Why?
|
| Molecular Sequence Data | 15 | 2012 | 18111 | 0.440 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 670 | 0.440 |
Why?
|
| Amines | 2 | 2013 | 276 | 0.440 |
Why?
|
| Mice | 30 | 2023 | 81201 | 0.430 |
Why?
|
| Curriculum | 5 | 2021 | 3605 | 0.430 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2011 | 407 | 0.430 |
Why?
|
| Mass Screening | 3 | 2021 | 5253 | 0.420 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2011 | 37 | 0.420 |
Why?
|
| Amino Acid Sequence | 13 | 2012 | 13814 | 0.420 |
Why?
|
| Cell Movement | 9 | 2012 | 5218 | 0.410 |
Why?
|
| Elastomers | 3 | 2008 | 71 | 0.410 |
Why?
|
| Lymphocytes | 1 | 2020 | 2617 | 0.400 |
Why?
|
| Rats, Wistar | 5 | 2016 | 1892 | 0.400 |
Why?
|
| Surface-Active Agents | 1 | 2012 | 159 | 0.400 |
Why?
|
| Maleimides | 1 | 2011 | 112 | 0.400 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 2023 | 140 | 0.400 |
Why?
|
| Venous Thrombosis | 3 | 2012 | 1239 | 0.390 |
Why?
|
| Fluorocarbons | 1 | 2016 | 452 | 0.390 |
Why?
|
| Hydrazones | 1 | 2011 | 102 | 0.390 |
Why?
|
| Femoral Artery | 7 | 2018 | 845 | 0.390 |
Why?
|
| Water | 4 | 2013 | 1395 | 0.390 |
Why?
|
| Staphylococcal Infections | 3 | 2016 | 1400 | 0.390 |
Why?
|
| Biomedical Technology | 1 | 2013 | 220 | 0.390 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 1387 | 0.380 |
Why?
|
| Phosphatidylethanolamines | 3 | 2001 | 134 | 0.380 |
Why?
|
| Treatment Outcome | 48 | 2021 | 63107 | 0.380 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2012 | 550 | 0.380 |
Why?
|
| Carrier Proteins | 2 | 2020 | 5023 | 0.380 |
Why?
|
| Microtechnology | 1 | 2011 | 70 | 0.370 |
Why?
|
| Intraoperative Complications | 9 | 2010 | 1198 | 0.370 |
Why?
|
| Phagocytosis | 1 | 2016 | 1539 | 0.370 |
Why?
|
| Time Factors | 38 | 2021 | 40075 | 0.370 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2020 | 362 | 0.370 |
Why?
|
| Protein Array Analysis | 2 | 2009 | 411 | 0.370 |
Why?
|
| Fibrillar Collagens | 1 | 2010 | 41 | 0.360 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 996 | 0.360 |
Why?
|
| Bioengineering | 1 | 2011 | 99 | 0.360 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 496 | 0.360 |
Why?
|
| Risk Assessment | 22 | 2021 | 23336 | 0.360 |
Why?
|
| Anticoagulants | 7 | 2023 | 4600 | 0.360 |
Why?
|
| Blood Coagulation | 7 | 2019 | 1127 | 0.360 |
Why?
|
| Glycosides | 2 | 2002 | 107 | 0.360 |
Why?
|
| Pichia | 1 | 2009 | 51 | 0.350 |
Why?
|
| Bacterial Proteins | 4 | 2016 | 3854 | 0.350 |
Why?
|
| Platelet Aggregation | 4 | 2021 | 798 | 0.350 |
Why?
|
| Wound Healing | 2 | 2020 | 2785 | 0.350 |
Why?
|
| Cells, Cultured | 17 | 2018 | 19233 | 0.350 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2010 | 101 | 0.350 |
Why?
|
| Ultrasonography | 5 | 2021 | 5984 | 0.350 |
Why?
|
| Glycosaminoglycans | 2 | 2002 | 624 | 0.340 |
Why?
|
| Mesenteric Arteries | 2 | 2000 | 183 | 0.340 |
Why?
|
| L-Selectin | 3 | 2017 | 214 | 0.330 |
Why?
|
| Fluorenes | 1 | 2010 | 160 | 0.330 |
Why?
|
| Computer Simulation | 6 | 2015 | 6194 | 0.330 |
Why?
|
| Arteriovenous Shunt, Surgical | 4 | 2006 | 277 | 0.330 |
Why?
|
| Polyproteins | 1 | 2008 | 11 | 0.330 |
Why?
|
| Angiotensin II | 2 | 2011 | 881 | 0.330 |
Why?
|
| Male | 95 | 2021 | 350115 | 0.330 |
Why?
|
| Catheterization, Peripheral | 4 | 2018 | 345 | 0.330 |
Why?
|
| Dendrimers | 4 | 2011 | 68 | 0.320 |
Why?
|
| Elasticity | 5 | 2010 | 657 | 0.320 |
Why?
|
| Apyrase | 2 | 2013 | 364 | 0.320 |
Why?
|
| Consensus | 4 | 2021 | 2960 | 0.320 |
Why?
|
| Sirolimus | 2 | 2013 | 1565 | 0.310 |
Why?
|
| Glycosylation | 5 | 2023 | 1128 | 0.310 |
Why?
|
| Neutrophils | 3 | 2017 | 3721 | 0.310 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2010 | 281 | 0.310 |
Why?
|
| Syndecans | 1 | 2007 | 79 | 0.310 |
Why?
|
| Models, Chemical | 3 | 2006 | 626 | 0.310 |
Why?
|
| Microscopy, Electron, Transmission | 4 | 2011 | 712 | 0.310 |
Why?
|
| Bioprosthesis | 2 | 2013 | 597 | 0.300 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2020 | 3773 | 0.300 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 18034 | 0.300 |
Why?
|
| Clinical Competence | 8 | 2019 | 4687 | 0.300 |
Why?
|
| Receptors, Thrombin | 3 | 1997 | 131 | 0.290 |
Why?
|
| Tissue Transplantation | 1 | 2007 | 130 | 0.290 |
Why?
|
| Glutaral | 3 | 2013 | 78 | 0.290 |
Why?
|
| Aneurysm, False | 6 | 2010 | 276 | 0.290 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2011 | 582 | 0.290 |
Why?
|
| Platelet Adhesiveness | 2 | 2020 | 161 | 0.280 |
Why?
|
| Models, Biological | 4 | 2015 | 9584 | 0.280 |
Why?
|
| Equipment Failure Analysis | 4 | 2015 | 868 | 0.280 |
Why?
|
| Calorimetry, Differential Scanning | 3 | 2014 | 94 | 0.280 |
Why?
|
| Up-Regulation | 5 | 2008 | 4222 | 0.280 |
Why?
|
| Adenosine Diphosphate | 2 | 2013 | 425 | 0.280 |
Why?
|
| Phosphatidylcholines | 2 | 2006 | 411 | 0.280 |
Why?
|
| Microspheres | 3 | 2004 | 777 | 0.280 |
Why?
|
| Magnetic Resonance Spectroscopy | 12 | 2009 | 3759 | 0.270 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1438 | 0.270 |
Why?
|
| Papio | 6 | 2013 | 656 | 0.270 |
Why?
|
| Equipment Design | 6 | 2015 | 3582 | 0.270 |
Why?
|
| Gels | 2 | 2006 | 427 | 0.270 |
Why?
|
| Hemodynamics | 2 | 2015 | 4196 | 0.270 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 850 | 0.270 |
Why?
|
| Carbohydrates | 2 | 2005 | 394 | 0.270 |
Why?
|
| Finite Element Analysis | 3 | 2015 | 431 | 0.270 |
Why?
|
| Cell Transplantation | 1 | 2007 | 477 | 0.260 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 714 | 0.260 |
Why?
|
| Balloon Occlusion | 2 | 2005 | 126 | 0.260 |
Why?
|
| Monocytes | 1 | 2015 | 2596 | 0.260 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 1917 | 0.260 |
Why?
|
| Heparinoids | 1 | 2004 | 7 | 0.260 |
Why?
|
| Cinnamates | 1 | 2005 | 60 | 0.260 |
Why?
|
| Drug Stability | 2 | 2020 | 291 | 0.260 |
Why?
|
| Adrenergic beta-Antagonists | 5 | 2009 | 1240 | 0.260 |
Why?
|
| Structure-Activity Relationship | 5 | 2020 | 3130 | 0.250 |
Why?
|
| Skin | 2 | 2017 | 4372 | 0.250 |
Why?
|
| Adoptive Transfer | 1 | 2007 | 844 | 0.250 |
Why?
|
| Carbohydrate Sequence | 4 | 2010 | 414 | 0.250 |
Why?
|
| Temperature | 5 | 2014 | 2204 | 0.250 |
Why?
|
| Postoperative Care | 3 | 2009 | 1487 | 0.250 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 12073 | 0.250 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2004 | 599 | 0.240 |
Why?
|
| Elastic Modulus | 4 | 2013 | 214 | 0.240 |
Why?
|
| Blood Vessels | 3 | 2012 | 1125 | 0.240 |
Why?
|
| Liposomes | 4 | 2010 | 759 | 0.240 |
Why?
|
| Carotid Artery Diseases | 5 | 2013 | 879 | 0.240 |
Why?
|
| Education, Medical | 1 | 2016 | 1722 | 0.240 |
Why?
|
| Endothelial Cells | 5 | 2019 | 3486 | 0.240 |
Why?
|
| E-Selectin | 2 | 2017 | 579 | 0.240 |
Why?
|
| Atherosclerosis | 4 | 2014 | 3444 | 0.240 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 4320 | 0.230 |
Why?
|
| Vascular Diseases | 2 | 2007 | 1161 | 0.230 |
Why?
|
| Capsules | 1 | 2004 | 196 | 0.230 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2002 | 482 | 0.230 |
Why?
|
| Linoleic Acid | 1 | 2004 | 157 | 0.230 |
Why?
|
| Oxidation-Reduction | 4 | 2006 | 2184 | 0.230 |
Why?
|
| Risk Factors | 29 | 2021 | 72296 | 0.230 |
Why?
|
| Molecular Weight | 3 | 2023 | 2255 | 0.230 |
Why?
|
| Abdominal Wall | 2 | 2017 | 157 | 0.230 |
Why?
|
| Circular Dichroism | 4 | 2011 | 354 | 0.220 |
Why?
|
| Quantum Dots | 1 | 2004 | 172 | 0.220 |
Why?
|
| Endothelium, Vascular | 5 | 2017 | 4459 | 0.220 |
Why?
|
| Alkenes | 1 | 2002 | 57 | 0.220 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3707 | 0.220 |
Why?
|
| Monosaccharides | 1 | 2002 | 70 | 0.220 |
Why?
|
| Catheterization | 3 | 2006 | 1470 | 0.210 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2016 | 675 | 0.210 |
Why?
|
| Endarterectomy | 3 | 2013 | 195 | 0.210 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 1970 | 0.210 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2022 | 67 | 0.210 |
Why?
|
| Continuity of Patient Care | 1 | 2009 | 1049 | 0.210 |
Why?
|
| Disaccharides | 1 | 2002 | 171 | 0.210 |
Why?
|
| Immobilized Proteins | 2 | 2013 | 25 | 0.210 |
Why?
|
| Surgical Procedures, Operative | 7 | 2009 | 1877 | 0.210 |
Why?
|
| Biomedical Research | 3 | 2019 | 3309 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2013 | 8300 | 0.210 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 780 | 0.210 |
Why?
|
| Flow Cytometry | 4 | 2016 | 5974 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2020 | 1677 | 0.210 |
Why?
|
| Tyrosine | 2 | 2023 | 1462 | 0.210 |
Why?
|
| Bone Marrow | 1 | 2012 | 2948 | 0.200 |
Why?
|
| Hexuronic Acids | 2 | 2015 | 144 | 0.200 |
Why?
|
| Glucuronic Acid | 2 | 2015 | 148 | 0.200 |
Why?
|
| Cell Survival | 3 | 2014 | 5882 | 0.200 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 2148 | 0.200 |
Why?
|
| Foreign-Body Migration | 3 | 2021 | 222 | 0.200 |
Why?
|
| Microscopy, Video | 2 | 2002 | 245 | 0.200 |
Why?
|
| Models, Molecular | 7 | 2020 | 5451 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 1790 | 0.200 |
Why?
|
| Peripheral Arterial Disease | 4 | 2018 | 1188 | 0.200 |
Why?
|
| Focal Adhesions | 3 | 2011 | 121 | 0.200 |
Why?
|
| Aneurysm, Infected | 3 | 2010 | 85 | 0.190 |
Why?
|
| RNA, Messenger | 7 | 2008 | 13035 | 0.190 |
Why?
|
| Viscosity | 3 | 2006 | 328 | 0.190 |
Why?
|
| Integrins | 2 | 2011 | 846 | 0.190 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 1375 | 0.190 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 426 | 0.190 |
Why?
|
| Lower Extremity | 3 | 2013 | 1158 | 0.190 |
Why?
|
| Pulmonary Embolism | 3 | 2006 | 2375 | 0.190 |
Why?
|
| Interdisciplinary Studies | 1 | 2021 | 89 | 0.190 |
Why?
|
| Sulfates | 2 | 2002 | 390 | 0.190 |
Why?
|
| Protein Binding | 6 | 2023 | 9384 | 0.190 |
Why?
|
| Subclavian Artery | 4 | 2011 | 130 | 0.190 |
Why?
|
| Hot Temperature | 4 | 2010 | 1356 | 0.190 |
Why?
|
| Sus scrofa | 2 | 2012 | 437 | 0.180 |
Why?
|
| Intermittent Claudication | 2 | 2013 | 309 | 0.180 |
Why?
|
| Polylysine | 2 | 2011 | 133 | 0.180 |
Why?
|
| Antigens, CD | 2 | 2013 | 4026 | 0.180 |
Why?
|
| Internship and Residency | 6 | 2021 | 5791 | 0.180 |
Why?
|
| Tunica Intima | 1 | 2002 | 464 | 0.180 |
Why?
|
| Carcinoma | 2 | 2023 | 2375 | 0.180 |
Why?
|
| Celiac Artery | 1 | 2000 | 69 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2011 | 2282 | 0.180 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1525 | 0.180 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 491 | 0.180 |
Why?
|
| Cells | 1 | 2021 | 168 | 0.180 |
Why?
|
| Chemokines | 2 | 2016 | 970 | 0.180 |
Why?
|
| Fibrin | 3 | 2020 | 506 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4925 | 0.180 |
Why?
|
| Solvents | 3 | 2005 | 302 | 0.170 |
Why?
|
| Electrolytes | 3 | 2011 | 282 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 4386 | 0.170 |
Why?
|
| Blood Proteins | 2 | 2019 | 1124 | 0.170 |
Why?
|
| Leg | 3 | 2013 | 1116 | 0.170 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 236 | 0.170 |
Why?
|
| Female | 64 | 2021 | 380193 | 0.170 |
Why?
|
| Scattering, Radiation | 3 | 2012 | 498 | 0.170 |
Why?
|
| Particle Size | 3 | 2012 | 1642 | 0.170 |
Why?
|
| Decision Trees | 1 | 2021 | 506 | 0.170 |
Why?
|
| Aged | 56 | 2021 | 163288 | 0.170 |
Why?
|
| Acrylic Resins | 3 | 2006 | 142 | 0.170 |
Why?
|
| Receptors, Fibronectin | 1 | 1998 | 39 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2008 | 1801 | 0.170 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 743 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 1525 | 0.170 |
Why?
|
| Peptide Fragments | 2 | 2010 | 5096 | 0.160 |
Why?
|
| Survival Analysis | 7 | 2009 | 10252 | 0.160 |
Why?
|
| Surgery Department, Hospital | 2 | 2019 | 175 | 0.160 |
Why?
|
| Heart Valve Prosthesis | 1 | 2007 | 1490 | 0.160 |
Why?
|
| Biocatalysis | 2 | 2016 | 167 | 0.160 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1998 | 143 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 4042 | 0.160 |
Why?
|
| Molecular Conformation | 1 | 2020 | 562 | 0.160 |
Why?
|
| Static Electricity | 2 | 2009 | 263 | 0.160 |
Why?
|
| Culture Media, Conditioned | 2 | 2014 | 537 | 0.160 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 15078 | 0.160 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 551 | 0.160 |
Why?
|
| Intestine, Small | 2 | 1999 | 1240 | 0.160 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2014 | 1632 | 0.160 |
Why?
|
| von Willebrand Factor | 1 | 2002 | 669 | 0.150 |
Why?
|
| Fibrinogen | 4 | 2020 | 894 | 0.150 |
Why?
|
| Hypertension, Renovascular | 1 | 1998 | 123 | 0.150 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2002 | 430 | 0.150 |
Why?
|
| Cell Migration Inhibition | 1 | 2017 | 96 | 0.150 |
Why?
|
| Carotid Arteries | 3 | 2008 | 950 | 0.150 |
Why?
|
| Syndecan-2 | 2 | 2007 | 23 | 0.150 |
Why?
|
| Morbidity | 4 | 2013 | 1768 | 0.150 |
Why?
|
| Aged, 80 and over | 30 | 2020 | 57776 | 0.150 |
Why?
|
| Mechanics | 2 | 2008 | 15 | 0.150 |
Why?
|
| Apolipoproteins E | 2 | 2014 | 1438 | 0.150 |
Why?
|
| Aldehydes | 2 | 2009 | 167 | 0.150 |
Why?
|
| Leukocyte Rolling | 1 | 2017 | 72 | 0.150 |
Why?
|
| Eligibility Determination | 1 | 2021 | 403 | 0.150 |
Why?
|
| Premedication | 1 | 1998 | 258 | 0.150 |
Why?
|
| Ultrasonography, Doppler | 2 | 2009 | 458 | 0.150 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2020 | 476 | 0.140 |
Why?
|
| Radial Artery | 1 | 2018 | 194 | 0.140 |
Why?
|
| Microcirculation | 1 | 2021 | 1287 | 0.140 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2017 | 102 | 0.140 |
Why?
|
| Preoperative Care | 3 | 2018 | 2251 | 0.140 |
Why?
|
| Fellowships and Scholarships | 2 | 2018 | 1078 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2016 | 23404 | 0.140 |
Why?
|
| Lipid Bilayers | 1 | 1999 | 381 | 0.140 |
Why?
|
| Glycolipids | 1 | 1997 | 204 | 0.140 |
Why?
|
| Thrombin Time | 2 | 2006 | 7 | 0.140 |
Why?
|
| Swine | 4 | 2017 | 5918 | 0.140 |
Why?
|
| Popliteal Artery | 1 | 2018 | 317 | 0.140 |
Why?
|
| Cyanates | 1 | 2016 | 20 | 0.140 |
Why?
|
| Catalysis | 2 | 2010 | 762 | 0.140 |
Why?
|
| Shear Strength | 3 | 2019 | 165 | 0.140 |
Why?
|
| Rabbits | 2 | 2017 | 4894 | 0.140 |
Why?
|
| Diffusion of Innovation | 1 | 2021 | 725 | 0.140 |
Why?
|
| Iliac Artery | 5 | 2006 | 364 | 0.140 |
Why?
|
| Electrophysiology | 1 | 1999 | 1308 | 0.140 |
Why?
|
| Cell Division | 3 | 2004 | 4569 | 0.140 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 639 | 0.140 |
Why?
|
| Carotid Stenosis | 5 | 2006 | 854 | 0.140 |
Why?
|
| Staining and Labeling | 2 | 2012 | 1101 | 0.140 |
Why?
|
| Extremities | 2 | 2017 | 866 | 0.140 |
Why?
|
| Georgia | 4 | 2010 | 186 | 0.140 |
Why?
|
| Drug Carriers | 2 | 2011 | 693 | 0.140 |
Why?
|
| Retrospective Studies | 34 | 2021 | 77460 | 0.140 |
Why?
|
| Glycoproteins | 2 | 2023 | 2266 | 0.130 |
Why?
|
| Microfluidics | 2 | 2015 | 662 | 0.130 |
Why?
|
| Patient Selection | 5 | 2021 | 4216 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2012 | 10483 | 0.130 |
Why?
|
| Antithrombin III | 2 | 2006 | 128 | 0.130 |
Why?
|
| Binding Sites | 3 | 2014 | 6111 | 0.130 |
Why?
|
| Decanoates | 1 | 2015 | 54 | 0.130 |
Why?
|
| Glycoconjugates | 1 | 2016 | 87 | 0.130 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2006 | 164 | 0.130 |
Why?
|
| Chi-Square Distribution | 8 | 2013 | 3508 | 0.130 |
Why?
|
| Adsorption | 2 | 2019 | 201 | 0.130 |
Why?
|
| Sutures | 2 | 2009 | 299 | 0.130 |
Why?
|
| Carotid Artery, Common | 1 | 1996 | 183 | 0.130 |
Why?
|
| Research Design | 2 | 2020 | 5984 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 3 | 2020 | 1831 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2021 | 1147 | 0.130 |
Why?
|
| Drug Implants | 2 | 2006 | 244 | 0.130 |
Why?
|
| Angiography | 5 | 2009 | 1639 | 0.130 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2005 | 506 | 0.130 |
Why?
|
| Middle Aged | 42 | 2021 | 213390 | 0.130 |
Why?
|
| Interleukins | 1 | 2020 | 791 | 0.130 |
Why?
|
| Polymerization | 1 | 2016 | 164 | 0.130 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1537 | 0.130 |
Why?
|
| United States | 20 | 2021 | 69872 | 0.130 |
Why?
|
| Anisotropy | 2 | 2020 | 1265 | 0.130 |
Why?
|
| Vascular System Injuries | 1 | 2018 | 250 | 0.130 |
Why?
|
| Renal Dialysis | 2 | 2003 | 1783 | 0.130 |
Why?
|
| Reoperation | 9 | 2013 | 4201 | 0.130 |
Why?
|
| Cell Aggregation | 1 | 2015 | 244 | 0.130 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2015 | 149 | 0.120 |
Why?
|
| Iatrogenic Disease | 2 | 2001 | 547 | 0.120 |
Why?
|
| Polyethylene Terephthalates | 2 | 1995 | 116 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2010 | 971 | 0.120 |
Why?
|
| Program Development | 2 | 2019 | 1316 | 0.120 |
Why?
|
| Physician-Patient Relations | 2 | 2019 | 3229 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2001 | 941 | 0.120 |
Why?
|
| Indicators and Reagents | 3 | 2004 | 462 | 0.120 |
Why?
|
| Glycerol | 1 | 2015 | 278 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2013 | 6539 | 0.120 |
Why?
|
| Veins | 1 | 2018 | 770 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 4 | 2009 | 9274 | 0.120 |
Why?
|
| Malpractice | 1 | 2019 | 572 | 0.120 |
Why?
|
| Hospitals, Teaching | 1 | 2019 | 1180 | 0.120 |
Why?
|
| Regeneration | 2 | 2020 | 1485 | 0.120 |
Why?
|
| Follow-Up Studies | 20 | 2013 | 39052 | 0.120 |
Why?
|
| Ligands | 2 | 2020 | 3282 | 0.120 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 1828 | 0.120 |
Why?
|
| Iridoids | 1 | 2013 | 16 | 0.120 |
Why?
|
| Prognosis | 5 | 2021 | 29060 | 0.120 |
Why?
|
| Thrombophlebitis | 1 | 1994 | 309 | 0.120 |
Why?
|
| Carotid Artery, Internal | 2 | 1996 | 445 | 0.120 |
Why?
|
| Equipment Failure | 3 | 2006 | 578 | 0.120 |
Why?
|
| Cardiovascular Diseases | 9 | 2010 | 15160 | 0.120 |
Why?
|
| Clinical Clerkship | 1 | 2019 | 532 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2015 | 10943 | 0.110 |
Why?
|
| Watchful Waiting | 1 | 2018 | 492 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2010 | 1115 | 0.110 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7721 | 0.110 |
Why?
|
| Light | 4 | 2008 | 1374 | 0.110 |
Why?
|
| Thrombolytic Therapy | 4 | 2010 | 2162 | 0.110 |
Why?
|
| Splenectomy | 2 | 1985 | 395 | 0.110 |
Why?
|
| Cell-Free System | 1 | 2013 | 344 | 0.110 |
Why?
|
| Methylcellulose | 1 | 2012 | 37 | 0.110 |
Why?
|
| Interferon-alpha | 2 | 2007 | 895 | 0.110 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1995 | 433 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 625 | 0.110 |
Why?
|
| Umbilical Veins | 3 | 1997 | 433 | 0.110 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2004 | 185 | 0.110 |
Why?
|
| Social Behavior | 1 | 2019 | 1127 | 0.110 |
Why?
|
| Evans Blue | 1 | 2012 | 45 | 0.110 |
Why?
|
| Survival Rate | 10 | 2013 | 12788 | 0.110 |
Why?
|
| Microscopy, Atomic Force | 2 | 2010 | 250 | 0.110 |
Why?
|
| Proteomics | 1 | 2005 | 3638 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 409 | 0.110 |
Why?
|
| Anesthesia, Local | 2 | 1996 | 275 | 0.100 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 2 | 2004 | 31 | 0.100 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 541 | 0.100 |
Why?
|
| Biofilms | 1 | 2016 | 617 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2004 | 250 | 0.100 |
Why?
|
| Cattle | 1 | 2017 | 3922 | 0.100 |
Why?
|
| Pancreatic Fistula | 1 | 2012 | 146 | 0.100 |
Why?
|
| Tropoelastin | 1 | 2011 | 29 | 0.100 |
Why?
|
| Dipyridamole | 1 | 2011 | 145 | 0.100 |
Why?
|
| Hematoma | 2 | 2010 | 758 | 0.100 |
Why?
|
| Creatinine | 3 | 2013 | 1919 | 0.100 |
Why?
|
| Colitis | 1 | 2020 | 1170 | 0.100 |
Why?
|
| Feedback | 1 | 2015 | 795 | 0.100 |
Why?
|
| Disulfides | 1 | 2013 | 457 | 0.100 |
Why?
|
| Combined Modality Therapy | 5 | 2013 | 8642 | 0.100 |
Why?
|
| Quality Improvement | 3 | 2020 | 3749 | 0.100 |
Why?
|
| Zymosan | 1 | 2011 | 124 | 0.100 |
Why?
|
| Students, Medical | 2 | 2019 | 1862 | 0.100 |
Why?
|
| Amino Acids | 1 | 2017 | 1737 | 0.100 |
Why?
|
| Thrombectomy | 2 | 2010 | 680 | 0.100 |
Why?
|
| Cell Line | 4 | 2023 | 16000 | 0.100 |
Why?
|
| Arm | 1 | 1994 | 589 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 727 | 0.100 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1994 | 478 | 0.100 |
Why?
|
| Biopharmaceutics | 1 | 2011 | 22 | 0.100 |
Why?
|
| Prothrombin | 1 | 2011 | 185 | 0.100 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2011 | 31 | 0.100 |
Why?
|
| Compressive Strength | 1 | 2011 | 169 | 0.100 |
Why?
|
| Immunoconjugates | 1 | 2018 | 901 | 0.100 |
Why?
|
| Lipoproteins | 1 | 1996 | 878 | 0.090 |
Why?
|
| Polyamines | 1 | 2011 | 120 | 0.090 |
Why?
|
| Aspirin | 1 | 2002 | 3283 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 20130 | 0.090 |
Why?
|
| Embolic Protection Devices | 1 | 2010 | 42 | 0.090 |
Why?
|
| Disclosure | 1 | 2016 | 736 | 0.090 |
Why?
|
| Complement Activation | 1 | 1992 | 453 | 0.090 |
Why?
|
| Complement C3 | 1 | 1992 | 461 | 0.090 |
Why?
|
| Pressure | 1 | 2014 | 1203 | 0.090 |
Why?
|
| Stereoisomerism | 1 | 2011 | 624 | 0.090 |
Why?
|
| Lidocaine | 1 | 1993 | 544 | 0.090 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2019 | 1008 | 0.090 |
Why?
|
| Base Sequence | 3 | 2009 | 12797 | 0.090 |
Why?
|
| Binding, Competitive | 2 | 2002 | 1157 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2009 | 5181 | 0.090 |
Why?
|
| Evidence-Based Medicine | 3 | 2011 | 3611 | 0.090 |
Why?
|
| Career Choice | 2 | 2007 | 744 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2017 | 565 | 0.090 |
Why?
|
| Hospital Mortality | 5 | 2020 | 5316 | 0.090 |
Why?
|
| Dermis | 1 | 2011 | 207 | 0.090 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2009 | 95 | 0.090 |
Why?
|
| Pancreatitis, Chronic | 1 | 2012 | 285 | 0.090 |
Why?
|
| Tendons | 1 | 2014 | 548 | 0.090 |
Why?
|
| Lasers | 1 | 2014 | 952 | 0.090 |
Why?
|
| Free Radicals | 2 | 2016 | 237 | 0.090 |
Why?
|
| Cations | 1 | 2009 | 232 | 0.090 |
Why?
|
| Gene Expression | 2 | 2020 | 7798 | 0.090 |
Why?
|
| Middle Cerebral Artery | 1 | 2010 | 264 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2265 | 0.090 |
Why?
|
| Age Factors | 8 | 2013 | 18373 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 1020 | 0.080 |
Why?
|
| Viscoelastic Substances | 1 | 2008 | 19 | 0.080 |
Why?
|
| Leukocytosis | 1 | 2010 | 247 | 0.080 |
Why?
|
| Graft Survival | 3 | 2010 | 3737 | 0.080 |
Why?
|
| Magnetics | 2 | 2004 | 606 | 0.080 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2012 | 503 | 0.080 |
Why?
|
| Intracranial Embolism | 1 | 2010 | 202 | 0.080 |
Why?
|
| Ulcer | 1 | 2010 | 209 | 0.080 |
Why?
|
| Kidney Function Tests | 3 | 2009 | 683 | 0.080 |
Why?
|
| Intraoperative Care | 1 | 2012 | 767 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 391 | 0.080 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3841 | 0.080 |
Why?
|
| Odds Ratio | 5 | 2013 | 9849 | 0.080 |
Why?
|
| Iliac Aneurysm | 2 | 2002 | 38 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 3037 | 0.080 |
Why?
|
| American Heart Association | 3 | 2010 | 1057 | 0.080 |
Why?
|
| Surgical Stapling | 1 | 2009 | 97 | 0.080 |
Why?
|
| Bucladesine | 1 | 2008 | 121 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 1998 | 2047 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 2505 | 0.080 |
Why?
|
| Total Quality Management | 1 | 2009 | 274 | 0.080 |
Why?
|
| Sex Factors | 4 | 2013 | 10400 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2014 | 14561 | 0.080 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2007 | 50 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4561 | 0.080 |
Why?
|
| Colectomy | 1 | 1993 | 680 | 0.080 |
Why?
|
| Premenopause | 1 | 2012 | 1033 | 0.080 |
Why?
|
| Foreign-Body Reaction | 1 | 2008 | 157 | 0.080 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2007 | 91 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 688 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 3 | 2003 | 2535 | 0.080 |
Why?
|
| Nephrectomy | 1 | 1994 | 1050 | 0.080 |
Why?
|
| Codon | 1 | 2009 | 611 | 0.080 |
Why?
|
| Genome, Human | 1 | 2021 | 4420 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 11486 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2014 | 1802 | 0.080 |
Why?
|
| Fibroblasts | 3 | 2006 | 4162 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2007 | 11366 | 0.080 |
Why?
|
| Intracranial Aneurysm | 1 | 2017 | 1197 | 0.080 |
Why?
|
| Massachusetts | 5 | 2019 | 8662 | 0.080 |
Why?
|
| Dilatation, Pathologic | 2 | 1999 | 520 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3531 | 0.070 |
Why?
|
| Nitric Oxide Donors | 1 | 2007 | 121 | 0.070 |
Why?
|
| Biomedical Engineering | 2 | 1999 | 296 | 0.070 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 290 | 0.070 |
Why?
|
| Acute Disease | 5 | 2006 | 7147 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 1060 | 0.070 |
Why?
|
| Solutions | 1 | 2007 | 426 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 14723 | 0.070 |
Why?
|
| Blood-Borne Pathogens | 1 | 2006 | 52 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 538 | 0.070 |
Why?
|
| Long-Term Care | 5 | 2008 | 607 | 0.070 |
Why?
|
| Phosphorylcholine | 1 | 2007 | 162 | 0.070 |
Why?
|
| Gene Library | 1 | 2009 | 1074 | 0.070 |
Why?
|
| Leukocytes | 1 | 2015 | 2045 | 0.070 |
Why?
|
| Saphenous Vein | 1 | 2010 | 532 | 0.070 |
Why?
|
| Coronary Angiography | 1 | 2018 | 4576 | 0.070 |
Why?
|
| Sympatholytics | 1 | 2006 | 83 | 0.070 |
Why?
|
| Motivation | 1 | 2016 | 1971 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2008 | 420 | 0.070 |
Why?
|
| Proportional Hazards Models | 4 | 2013 | 12356 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1588 | 0.070 |
Why?
|
| Iodine Radioisotopes | 2 | 2001 | 1032 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2015 | 2504 | 0.070 |
Why?
|
| Cryoelectron Microscopy | 1 | 2009 | 576 | 0.070 |
Why?
|
| Limb Salvage | 3 | 2013 | 433 | 0.070 |
Why?
|
| Factor X | 1 | 2006 | 64 | 0.070 |
Why?
|
| Cause of Death | 2 | 2009 | 3582 | 0.070 |
Why?
|
| Chemical Precipitation | 1 | 2005 | 179 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 752 | 0.070 |
Why?
|
| Membranes | 1 | 2006 | 173 | 0.070 |
Why?
|
| Kidney | 3 | 2001 | 7184 | 0.070 |
Why?
|
| Prosthesis Implantation | 2 | 2008 | 642 | 0.070 |
Why?
|
| Bacterial Infections | 2 | 2003 | 1401 | 0.070 |
Why?
|
| Multivariate Analysis | 7 | 2013 | 12244 | 0.070 |
Why?
|
| Iliac Vein | 1 | 2006 | 72 | 0.070 |
Why?
|
| Glass | 1 | 2006 | 114 | 0.070 |
Why?
|
| Air | 1 | 2006 | 182 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2006 | 549 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2004 | 1660 | 0.070 |
Why?
|
| Vascular Patency | 2 | 2012 | 887 | 0.070 |
Why?
|
| Efficiency | 2 | 2019 | 462 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 2 | 2012 | 1486 | 0.060 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2006 | 153 | 0.060 |
Why?
|
| U937 Cells | 1 | 2005 | 268 | 0.060 |
Why?
|
| Intestinal Perforation | 1 | 1987 | 253 | 0.060 |
Why?
|
| Alkynes | 1 | 2006 | 306 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2173 | 0.060 |
Why?
|
| Comorbidity | 4 | 2010 | 10388 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2700 | 0.060 |
Why?
|
| Spinal Cord | 1 | 1993 | 1810 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2010 | 1158 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 972 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3848 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 2513 | 0.060 |
Why?
|
| Galactose | 1 | 2005 | 306 | 0.060 |
Why?
|
| Albumins | 1 | 2007 | 568 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 452 | 0.060 |
Why?
|
| Drug-Eluting Stents | 2 | 2009 | 753 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2012 | 3914 | 0.060 |
Why?
|
| Intestinal Fistula | 1 | 1985 | 140 | 0.060 |
Why?
|
| Gelatin | 1 | 2006 | 225 | 0.060 |
Why?
|
| Chromatography, Thin Layer | 1 | 2004 | 223 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2011 | 4010 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2005 | 323 | 0.060 |
Why?
|
| Liver | 2 | 2010 | 7475 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2011 | 828 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1736 | 0.060 |
Why?
|
| Carotid Artery Thrombosis | 2 | 2000 | 53 | 0.060 |
Why?
|
| Uterine Diseases | 1 | 1985 | 135 | 0.060 |
Why?
|
| Phenotype | 3 | 2015 | 16367 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2018 | 7730 | 0.060 |
Why?
|
| Diverticulitis, Colonic | 1 | 1985 | 128 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1420 | 0.060 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2005 | 247 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 2765 | 0.060 |
Why?
|
| Colonic Diseases | 1 | 1985 | 202 | 0.060 |
Why?
|
| Cadaver | 1 | 2007 | 1337 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1620 | 0.060 |
Why?
|
| Carbon | 1 | 2007 | 687 | 0.060 |
Why?
|
| Acids | 1 | 2004 | 127 | 0.060 |
Why?
|
| Platelet Count | 1 | 2006 | 780 | 0.060 |
Why?
|
| Fistula | 1 | 1985 | 220 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2003 | 237 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1247 | 0.060 |
Why?
|
| Heart Valve Diseases | 2 | 2009 | 1074 | 0.060 |
Why?
|
| Cardiology | 2 | 2012 | 1668 | 0.060 |
Why?
|
| Dimerization | 1 | 2004 | 895 | 0.060 |
Why?
|
| Trypsin | 1 | 2004 | 511 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2005 | 1454 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2014 | 1519 | 0.060 |
Why?
|
| Boston | 4 | 2019 | 9312 | 0.060 |
Why?
|
| Mesangial Cells | 1 | 2022 | 24 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2010 | 1640 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19905 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 6313 | 0.050 |
Why?
|
| Radiography | 6 | 2012 | 7023 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2005 | 629 | 0.050 |
Why?
|
| Glomerular Mesangium | 1 | 2022 | 108 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2002 | 209 | 0.050 |
Why?
|
| Prospective Studies | 8 | 2020 | 53290 | 0.050 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2002 | 111 | 0.050 |
Why?
|
| Severity of Illness Index | 5 | 2013 | 15535 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2004 | 682 | 0.050 |
Why?
|
| Embolism, Cholesterol | 1 | 2002 | 34 | 0.050 |
Why?
|
| Streptavidin | 1 | 2002 | 81 | 0.050 |
Why?
|
| Anesthesia | 6 | 2009 | 1561 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2007 | 764 | 0.050 |
Why?
|
| Epigastric Arteries | 1 | 2002 | 96 | 0.050 |
Why?
|
| Vinculin | 1 | 2002 | 62 | 0.050 |
Why?
|
| Registries | 2 | 2020 | 8091 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10183 | 0.050 |
Why?
|
| Logistic Models | 6 | 2013 | 13409 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2002 | 287 | 0.050 |
Why?
|
| Partial Thromboplastin Time | 1 | 2002 | 206 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2013 | 1796 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2004 | 454 | 0.050 |
Why?
|
| Risk | 2 | 2012 | 9688 | 0.050 |
Why?
|
| Acrylates | 1 | 2001 | 89 | 0.050 |
Why?
|
| Acrylamides | 1 | 2003 | 255 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2010 | 2499 | 0.050 |
Why?
|
| Feasibility Studies | 3 | 2009 | 5077 | 0.050 |
Why?
|
| Collateral Circulation | 1 | 2002 | 287 | 0.050 |
Why?
|
| Stroke | 4 | 2013 | 9981 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2002 | 3001 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 1284 | 0.050 |
Why?
|
| Incidence | 6 | 2018 | 20952 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1677 | 0.050 |
Why?
|
| Myofibrils | 1 | 2001 | 146 | 0.050 |
Why?
|
| Embolization, Therapeutic | 2 | 2002 | 1392 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 730 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 1681 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 9955 | 0.050 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2020 | 53 | 0.050 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2000 | 23 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2022 | 517 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 4 | 1996 | 1504 | 0.050 |
Why?
|
| Doxycycline | 1 | 2002 | 326 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2002 | 219 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1641 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 2732 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 8949 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 2760 | 0.050 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 460 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3702 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 2020 | 122 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2000 | 336 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3589 | 0.040 |
Why?
|
| Lectins | 1 | 2002 | 513 | 0.040 |
Why?
|
| Adult | 17 | 2020 | 214052 | 0.040 |
Why?
|
| CHO Cells | 1 | 2002 | 1409 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2001 | 898 | 0.040 |
Why?
|
| Culture Media | 1 | 2002 | 909 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2007 | 2740 | 0.040 |
Why?
|
| Viscera | 1 | 2000 | 139 | 0.040 |
Why?
|
| Solubility | 1 | 2001 | 1088 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 1431 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 1821 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2006 | 1708 | 0.040 |
Why?
|
| Pneumococcal Infections | 1 | 1984 | 497 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2008 | 2969 | 0.040 |
Why?
|
| Hemorheology | 1 | 2019 | 145 | 0.040 |
Why?
|
| Peer Review, Health Care | 1 | 2019 | 75 | 0.040 |
Why?
|
| Hemostatics | 1 | 2001 | 229 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 1120 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 995 | 0.040 |
Why?
|
| Cricetinae | 1 | 2002 | 2475 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2001 | 625 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4424 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 1888 | 0.040 |
Why?
|
| Integrin alpha4beta1 | 1 | 1998 | 121 | 0.040 |
Why?
|
| Inflammation | 2 | 2009 | 10637 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 3508 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.040 |
Why?
|
| Arteriovenous Fistula | 1 | 2001 | 315 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1950 | 0.040 |
Why?
|
| Chromatography, Gel | 1 | 1999 | 668 | 0.040 |
Why?
|
| Apoptosis | 2 | 2012 | 9724 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 4251 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16690 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2019 | 322 | 0.040 |
Why?
|
| Chlorates | 1 | 1997 | 13 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 3154 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2009 | 2531 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 2 | 2001 | 935 | 0.040 |
Why?
|
| Pelvis | 1 | 2002 | 730 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 1133 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2004 | 1184 | 0.040 |
Why?
|
| Heart Diseases | 2 | 2009 | 2789 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1997 | 192 | 0.040 |
Why?
|
| United States Food and Drug Administration | 2 | 2002 | 1584 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1997 | 347 | 0.040 |
Why?
|
| Quality of Health Care | 2 | 2009 | 4369 | 0.040 |
Why?
|
| Hemolysis | 1 | 2019 | 420 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2646 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 374 | 0.040 |
Why?
|
| Learning Curve | 1 | 2018 | 208 | 0.040 |
Why?
|
| Calgranulin B | 1 | 2017 | 84 | 0.040 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 1997 | 90 | 0.040 |
Why?
|
| Ticlopidine | 1 | 2002 | 899 | 0.040 |
Why?
|
| Forecasting | 1 | 2006 | 2951 | 0.040 |
Why?
|
| Herbicides | 1 | 1997 | 100 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1225 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 1537 | 0.040 |
Why?
|
| Bromine Compounds | 1 | 1996 | 2 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2017 | 205 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1678 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2018 | 406 | 0.030 |
Why?
|
| Life Tables | 1 | 1996 | 370 | 0.030 |
Why?
|
| North America | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Faculty | 1 | 2019 | 387 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 2 | 2013 | 2166 | 0.030 |
Why?
|
| Random Allocation | 1 | 2020 | 2428 | 0.030 |
Why?
|
| Goals | 1 | 2021 | 707 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2008 | 504 | 0.030 |
Why?
|
| Risk Management | 1 | 2019 | 571 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2006 | 2725 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2012 | 21748 | 0.030 |
Why?
|
| Algorithms | 3 | 2009 | 13882 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2007 | 2987 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2015 | 162 | 0.030 |
Why?
|
| Blood Loss, Surgical | 2 | 2012 | 662 | 0.030 |
Why?
|
| Polystyrenes | 1 | 1995 | 112 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 1572 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 3922 | 0.030 |
Why?
|
| Aftercare | 1 | 2001 | 870 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 643 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2015 | 251 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2007 | 4397 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 2126 | 0.030 |
Why?
|
| Postoperative Period | 1 | 1999 | 1842 | 0.030 |
Why?
|
| Biological Transport | 1 | 1999 | 2120 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 560 | 0.030 |
Why?
|
| Cervical Plexus | 1 | 1993 | 12 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2018 | 615 | 0.030 |
Why?
|
| Embolectomy | 1 | 1994 | 120 | 0.030 |
Why?
|
| Injections, Intradermal | 1 | 1993 | 117 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 708 | 0.030 |
Why?
|
| Carbamates | 1 | 1995 | 196 | 0.030 |
Why?
|
| Physical Examination | 2 | 2009 | 1237 | 0.030 |
Why?
|
| Coronary Artery Bypass | 2 | 2011 | 2288 | 0.030 |
Why?
|
| Directed Molecular Evolution | 1 | 2014 | 160 | 0.030 |
Why?
|
| Glucose | 1 | 2005 | 4398 | 0.030 |
Why?
|
| Paraplegia | 1 | 1994 | 169 | 0.030 |
Why?
|
| Endoscopy | 1 | 2003 | 1787 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 430 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1581 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1461 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 3338 | 0.030 |
Why?
|
| Axillary Artery | 1 | 1992 | 50 | 0.030 |
Why?
|
| Kidney Diseases | 2 | 2017 | 2148 | 0.030 |
Why?
|
| Perception | 1 | 2019 | 1198 | 0.030 |
Why?
|
| Emergencies | 2 | 2013 | 1170 | 0.030 |
Why?
|
| Staphylococcus epidermidis | 1 | 2013 | 117 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2001 | 1912 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 500 | 0.030 |
Why?
|
| Recurrence | 5 | 2012 | 8340 | 0.030 |
Why?
|
| Cell Death | 1 | 1997 | 1707 | 0.030 |
Why?
|
| Retreatment | 1 | 2013 | 610 | 0.030 |
Why?
|
| Administration, Topical | 1 | 1993 | 690 | 0.030 |
Why?
|
| Blood Pressure | 2 | 1998 | 8551 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1341 | 0.020 |
Why?
|
| Pyridines | 1 | 2002 | 2825 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 570 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1879 | 0.020 |
Why?
|
| Publishing | 1 | 2018 | 833 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2019 | 2488 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1997 | 1261 | 0.020 |
Why?
|
| Length of Stay | 4 | 2012 | 6311 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2015 | 2716 | 0.020 |
Why?
|
| Sepsis | 1 | 1984 | 2593 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2001 | 3461 | 0.020 |
Why?
|
| Infant | 4 | 2020 | 35134 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2004 | 6254 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2011 | 475 | 0.020 |
Why?
|
| Antibodies | 1 | 1997 | 2460 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2010 | 292 | 0.020 |
Why?
|
| Orthopedic Procedures | 1 | 2019 | 1289 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2011 | 336 | 0.020 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2008 | 125 | 0.020 |
Why?
|
| Cognition | 1 | 2006 | 6770 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2926 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1351 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 6489 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2020 | 2071 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 841 | 0.020 |
Why?
|
| Device Removal | 1 | 2013 | 656 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1997 | 2865 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2007 | 92 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2013 | 4217 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 5895 | 0.020 |
Why?
|
| Lung | 1 | 2005 | 9857 | 0.020 |
Why?
|
| Blood | 1 | 1989 | 598 | 0.020 |
Why?
|
| Nerve Block | 1 | 1993 | 644 | 0.020 |
Why?
|
| Colostomy | 1 | 1987 | 99 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2011 | 775 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 3395 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 1485 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1999 | 2400 | 0.020 |
Why?
|
| Ileostomy | 1 | 1987 | 119 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2011 | 1342 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2012 | 985 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 687 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1994 | 931 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2008 | 502 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2005 | 114 | 0.020 |
Why?
|
| Pancreas | 1 | 2012 | 1687 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2009 | 498 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 197 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2010 | 544 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2009 | 841 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2006 | 212 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 3528 | 0.020 |
Why?
|
| Family Relations | 1 | 2007 | 321 | 0.020 |
Why?
|
| Intestinal Neoplasms | 1 | 1987 | 319 | 0.020 |
Why?
|
| Adolescent | 5 | 2020 | 85779 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 818 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3511 | 0.010 |
Why?
|
| Ampicillin | 1 | 1984 | 139 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2010 | 957 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 7182 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.010 |
Why?
|
| Contrast Media | 1 | 2017 | 5300 | 0.010 |
Why?
|
| Patient Preference | 1 | 2011 | 889 | 0.010 |
Why?
|
| Haemophilus influenzae | 1 | 1984 | 172 | 0.010 |
Why?
|
| Streptococcus | 1 | 1984 | 197 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2010 | 1547 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 968 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 2006 | 440 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 35425 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5953 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2013 | 2708 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2006 | 1107 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2010 | 1099 | 0.010 |
Why?
|
| Disease Progression | 2 | 2013 | 13286 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1987 | 530 | 0.010 |
Why?
|
| Exercise Test | 1 | 2009 | 2073 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1873 | 0.010 |
Why?
|
| Mentors | 1 | 2007 | 631 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2001 | 193 | 0.010 |
Why?
|
| Echocardiography | 1 | 1994 | 5099 | 0.010 |
Why?
|
| Brachytherapy | 1 | 2009 | 1248 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 1984 | 403 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 2556 | 0.010 |
Why?
|
| Penicillins | 1 | 1984 | 380 | 0.010 |
Why?
|
| Leukocyte Migration-Inhibitory Factors | 1 | 1980 | 12 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2002 | 263 | 0.010 |
Why?
|
| Workload | 1 | 2007 | 849 | 0.010 |
Why?
|
| Critical Illness | 1 | 2013 | 2670 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1996 | 7914 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2000 | 234 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2013 | 3318 | 0.010 |
Why?
|
| Time | 1 | 2002 | 542 | 0.010 |
Why?
|
| Uremia | 1 | 2001 | 200 | 0.010 |
Why?
|
| Coronary Artery Disease | 2 | 2009 | 6486 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3252 | 0.010 |
Why?
|
| Immunization | 1 | 1984 | 1256 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2009 | 1887 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1985 | 927 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9445 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2009 | 2585 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 5534 | 0.010 |
Why?
|
| Rupture | 1 | 2000 | 433 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2002 | 638 | 0.010 |
Why?
|
| Wounds, Gunshot | 1 | 1985 | 563 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2200 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 2073 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2001 | 25628 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 1912 | 0.010 |
Why?
|
| Lymphokines | 1 | 1980 | 949 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1980 | 470 | 0.010 |
Why?
|
| Colon | 1 | 1985 | 1772 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1980 | 803 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2009 | 6442 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2373 | 0.010 |
Why?
|
| Life Style | 1 | 2007 | 3835 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2012 | 40559 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6364 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5263 | 0.010 |
Why?
|
| Internet | 1 | 2007 | 3056 | 0.010 |
Why?
|
| Medicare | 1 | 2012 | 6566 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 5749 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1987 | 2304 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56429 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2001 | 1095 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1996 | 931 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11718 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2002 | 2684 | 0.010 |
Why?
|
| Blindness | 1 | 1996 | 615 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2005 | 3680 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2001 | 41005 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1985 | 12961 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1980 | 5524 | 0.010 |
Why?
|
| Physicians | 1 | 2005 | 4567 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2001 | 9145 | 0.000 |
Why?
|
| Child | 2 | 2001 | 77709 | 0.000 |
Why?
|
| Smoking | 1 | 2002 | 8987 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1990 | 6366 | 0.000 |
Why?
|
| Hypertension | 1 | 2001 | 8479 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1980 | 370 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1980 | 1386 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1980 | 1035 | 0.000 |
Why?
|